Fingerprint
Dive into the research topics of 'Efficacy and safety of erlotinib HCl, an epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor, in patients with advanced ovarian carcinoma: Results from a phase II multicenter study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically